RYBELSUS 14 MG COM OR CT BL AL AL X 10
Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil
-
Registration number
1176600370099 -
GGREM
526620120009607 -
Barcode
7897705202746
What the source publishes
- Holder
- NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA
- Active ingredients
- SEMAGLUTIDA
- Package
- 14 MG COM OR CT BL AL AL X 10
- Product type
- Biológico
- Therapeutic class
- A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1
Names this record is found by
Complete source data
{
"name": "RYBELSUS 14 MG COM OR CT BL AL AL X 10",
"holder": "NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA",
"stripe": null,
"barcodes": [
"7897705202746"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526620120009607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "82.277.955/0001-55",
"priceRegime": "Regulado",
"productName": "RYBELSUS",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "14 MG COM OR CT BL AL AL X 10",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "286.92",
"icms-12": "326.05",
"icms-17": "345.69",
"icms-18": "349.90",
"icms-19": "354.22",
"icms-20": "358.65",
"icms-21": "363.19",
"icms-22": "367.85",
"icms-23": "372.62",
"icms-17.5": "347.78",
"icms-19.5": "356.42",
"icms-20.5": "360.91",
"icms-22.5": "370.22",
"icms-12-alc": "291.11",
"icms-17-alc": "308.65",
"icms-18-alc": "312.41",
"icms-19-alc": "316.27",
"icms-20-alc": "320.22",
"icms-21-alc": "324.28",
"icms-22-alc": "328.43",
"icms-23-alc": "332.70",
"withoutTaxes": "256.18",
"icms-17.5-alc": "310.52",
"icms-19.5-alc": "318.23",
"icms-20.5-alc": "322.24",
"icms-22.5-alc": "330.55"
},
"pisCofinsList": "Negativa",
"substanceText": "SEMAGLUTIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "384.89",
"icms-12": "437.38",
"icms-17": "463.73",
"icms-18": "469.38",
"icms-19": "475.17",
"icms-20": "481.12",
"icms-21": "487.21",
"icms-22": "493.46",
"icms-23": "499.86",
"icms-17.5": "466.53",
"icms-19.5": "478.12",
"icms-20.5": "484.15",
"icms-22.5": "496.64",
"icms-12-alc": "402.44",
"icms-17-alc": "426.69",
"icms-18-alc": "431.89",
"icms-19-alc": "437.22",
"icms-20-alc": "442.69",
"icms-21-alc": "448.30",
"icms-22-alc": "454.04",
"icms-23-alc": "459.94",
"withoutTaxes": "354.15",
"icms-17.5-alc": "429.28",
"icms-19.5-alc": "439.93",
"icms-20.5-alc": "445.48",
"icms-22.5-alc": "456.97"
},
"invalidBarcodes": [],
"activeSubstances": [
"SEMAGLUTIDA"
],
"therapeuticClass": "A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1176600370099",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "A10S",
"commercialDestination": null,
"registrationNumberFlag": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526620120009607"